LEATSIDE HEALTH CENTRE
FORTH NOWETH, REDRUTH
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 37 | 41 | 90.2% | |
| HF 4 | 2011 | 41 | 49 | 83.7% | |
| HF 4 | 2012 | 41 | 44 | 93.2% | |
| HF 4 | 2013 | 49 | 52 | 94.2% | |
| HF004 | 2014 | 55 | 57 | 96.5% | |
| HF004 | 2015 | 65 | 65 | 100.0% | |
| HF004 | 2016 | 61 | 63 | 96.8% | |
| HF004 | 2017 | 63 | 63 | 100.0% | |
| HF004 | 2018 | 66 | 70 | 94.3% | |
| HF004 | 2020 | 64 | 73 | 87.7% | |
| HF006 | 2021 | 95 | 99 | 96.0% | |
| HF006 | 2022 | 174 | 186 | 93.5% | |
| HF006 | 2023 | 198 | 202 | 98.0% |
